Fidelity Investments’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.5M Buy
2,067,222
+307,324
+17% +$3.91M ﹤0.01% 1674
2025
Q4
$15.8M Sell
1,759,898
-92,394
-5% -$1.27M ﹤0.01% 1860
2025
Q3
$32M Buy
1,852,292
+331,744
+22% +$4.09M ﹤0.01% 1608
2025
Q2
$14.3M Sell
1,520,548
-69,754
-4% -$573K ﹤0.01% 1797
2025
Q1
$11.3M Buy
1,590,302
+337,463
+27% +$3.41M ﹤0.01% 1867
2024
Q4
$14.6M Sell
1,252,839
-1,086,683
-46% -$17M ﹤0.01% 1827
2024
Q3
$48.1M Buy
2,339,522
+111,104
+5% +$2.56M ﹤0.01% 1393
2024
Q2
$49.9M Buy
2,228,418
+22,076
+1% +$526K ﹤0.01% 1313
2024
Q1
$60.7M Buy
2,206,342
+1,019,739
+86% +$28.3M ﹤0.01% 1255
2023
Q4
$36.2M Sell
1,186,603
-306,425
-21% -$8.81M ﹤0.01% 1416
2023
Q3
$47.2M Sell
1,493,028
-16,885
-1% -$655K ﹤0.01% 1263
2023
Q2
$61.6M Buy
1,509,913
+304,256
+25% +$12.3M 0.01% 1192
2023
Q1
$44.9M Sell
1,205,657
-1,216,295
-50% -$47.7M ﹤0.01% 1304
2022
Q4
$84.5M Sell
2,421,952
-204,801
-8% -$9.74M 0.01% 1034
2022
Q3
$147M Sell
2,626,753
-678,653
-21% -$42.1M 0.02% 799
2022
Q2
$171M Buy
3,305,406
+510,481
+18% +$25.9M 0.02% 756
2022
Q1
$203M Sell
2,794,925
-1,082,848
-28% -$91.7M 0.02% 765
2021
Q4
$459M Buy
3,877,773
+697,405
+22% +$87.4M 0.03% 495
2021
Q3
$427M Buy
3,180,368
+451,566
+17% +$68.4M 0.03% 494
2021
Q2
$442M Buy
2,728,802
+1,577,813
+137% +$123M 0.03% 480
2021
Q1
$92.4M Sell
1,150,989
-131,437
-10% -$8.82M 0.01% 1099
2020
Q4
$69.8M Sell
1,282,426
-96,538
-7% -$3.51M 0.01% 1187
2020
Q3
$27.4M Sell
1,378,964
-229,667
-14% -$4.79M ﹤0.01% 1435
2020
Q2
$33.8M Buy
1,608,631
+776,887
+93% +$13.2M ﹤0.01% 1324
2020
Q1
$10.2M Sell
831,744
-2,183
-0.3% -$29.4K ﹤0.01% 1685
2019
Q4
$12.2M Buy
833,927
+760,435
+1,035% +$10.6M ﹤0.01% 1780
2019
Q3
$981K Sell
73,492
-2,027,155
-97% -$32.3M ﹤0.01% 2424
2019
Q2
$34.4M Sell
2,100,647
-158,656
-7% -$2.49M ﹤0.01% 1395
2019
Q1
$38.6M Sell
2,259,303
-155,629
-6% -$2.32M ﹤0.01% 1326
2018
Q4
$33M Sell
2,414,932
-45,714
-2% -$850K ﹤0.01% 1349
2018
Q3
$70.4M Sell
2,460,646
-68,109
-3% -$1.98M 0.01% 1103
2018
Q2
$69.2M Sell
2,528,755
-1,221,341
-33% -$29.6M 0.01% 1120
2018
Q1
$79.1M Sell
3,750,096
-536,482
-13% -$13.2M 0.01% 1083
2017
Q4
$82.4M Buy
4,286,578
+1,075,314
+33% +$24.8M 0.01% 1084
2017
Q3
$79.8M Sell
3,211,264
-15,568
-0.5% -$293K 0.01% 1077
2017
Q2
$51.6M Sell
3,226,832
-774,103
-19% -$10.8M 0.01% 1280
2017
Q1
$56.4M Sell
4,000,935
-764,546
-16% -$10.3M 0.01% 1249
2016
Q4
$62.5M Sell
4,765,481
-499,326
-9% -$7.5M 0.01% 1193
2016
Q3
$89.6M Buy
5,264,807
+10,400
+0.2% +$201K 0.01% 1030
2016
Q2
$112M Buy
+5,254,407
New +$140M 0.02% 927

Other funds holding NTLA